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As part of our research group continuous efforts to find alternative treatments for cancer, the
aqueous ethanol extracts of fifty-six plants collected from Egypt were screened in vitro for their
antileukemic activity against leukemia K562 cell line (Fig.1 and 2). Sesbania sesban L. Merr. (SS;
Egyptian riverhemp) was one of the active plants that were selected for further chemical and
biological investigations. Bio-guided fractionation of SS leaves hydroethanolic extract resulted in
isolation of one undescribed compound (33) (Hederatriol 3-O-β-D-glucuronic acid methyl ester) as
well as thirty-four known compounds. Seven compounds (34, 22, 20, 24, 21, 19, 35) showed high
anti-proliferative effect (IC50 = 22.3, 30.8, 31.3, 33.7, 36.6, 37.5, 41.5 µM, respectively), while four
compounds (32, 5, 29, 1) showed milder activity with (IC50 = 56.4, 67.6, 83.3, 112.3 µM,
respectively). A mechanistic study was further carried out on a molecular genetics level against
several transcription factors signaling pathways that are incorporated in the incidence of cancer.
The results showed that compounds (22, 21) demonstrated specific inhibition of Wnt pathway
(IC50 = 3.8, 4.6 µM, respectively), while compound (22) showed specific inhibition of Smad
pathway (IC50 = 3.8 µM). Compound (34) was shown to strongly altered the signaling pathways
of Smad and E2F (IC50 = 5 µM) (Fig.3). The bioactive metabolites were furtherly investigated in
silico by docking against several targets related to K562 cell line. The results showed that
compounds 22 and 34 exhibited a strong binding affinity towards topoisomerase (docking score =
-7.8056 and -9.2972 Kcal/Mole, respectively) (Fig.4). Compounds 22 and 34 demonstrated strong
binding affinity towards EGFR-Tyrosine kinase (docking score = -7.1200, and -7.350 Kcal/Mole,
respectively). Moreover, compound 34 showed a strong binding affinity towards Abl kinase
(docking score = -7.0463 Kcal/Mole).
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One new compound (33), in addition to thirty-four known compounds were isolated from the
leaves of Sesbania sesban encompassing nineteen triterpenoids (3-7, 19-24, 26, 29-35), three
steroids (2, 8, 25), eleven flavonoid glycosides (10-18, 27-28), one fatty alcohol (1) and one
phenolic compound (9). Thirty of them (1, 3-4, 6-18, 20-33, 35) are reported for the first time
from this species. The antileukemic activity of the isolated compounds was evaluated against
leukemia K562 cell line in vitro and eleven triterpenoids exhibited a remarkable antileukemic
activity against this cell line. Compounds 34 (Oleanolic acid 3-O-β-D-glucuronopyranoside)
and 22 (Jacoumaric acid) exhibited the strongest activity with an IC50 value of 22.3, 30.8 µM,
respectively.
Fig. 1. IC50 [µM] of the active isolated compounds against leukemia K562 cell line
Fig. 2. IC50 [µM] of active isolated compounds against selectedtranscription factor signaling pathways
Fig.3. Mode of action of active isolated compounds against;
Smad, Wnt and E2F Signaling pathways
Fig. 5. Docking of compounds 22 and 34 with topoisomerase
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Fig. 4. SAR of different types of triterpenes
PROPOSED MECHANISM OF ACTION
The antileukemic activities of these
compounds could mainly attributed to
targeting the two transcription factors
signaling pathways; Smad and Wnt that
were previously reported to be
incorporated in the incidence and
pathogenesis of Leukemia. 3β-O-(cis-p-
Coumaroyl)-2α-hydroxyurs-12-en-28-oic
acid (21), Jacoumaric acid (22) showed
specific inhibition of Wnt pathway
though stimulation of β-catenin
degradation and preventing its
accumulation while Jacoumaric acid (22)
and Oleanolic acid 3-O-β-D-
glucuronopyranoside (34) showed
specific inhibition of Smad signaling
pathways by acting as antagonists of
TGF-β1 binding to its receptor (Fig.3).
